Salma AlBahrani
-
- Antibiotic Use and Resistance 3
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies 10
- SARS-CoV-2 and COVID-19 Research 6
- General Dentistry top 10%
-
- Long-Term Effects of COVID-19 9
-
- Pneumonia and Respiratory Infections 3
-
- Antibiotic Resistance in Bacteria 3
-
- Antibiotics Pharmacokinetics and Efficacy 3
-
- COVID-19 and healthcare impacts 3
- Co-authors
- Jaffar A. Al‐TawfiqAbbas Al MutairSaad AlhumaidAli A. RabaanRaghavendra TirupathiAbeer N. AlshukairiKuldeep DhamaMazin Barry
- Journals
- SHILAP Revista de lepidopterología (1 paper)International Journal of Environmental Research and Public Health (1 paper)Frontiers in Pharmacology (1 paper)
- Partner nations
- Saudi ArabiaUnited StatesMyanmar
In The Last Decade
Salma AlBahrani
22 papers receiving 255 citations
Peers
Comparison fields: 5 of 74
- Applied Microbiology and Biotechnology 25
- Infectious Diseases 153
- General Dentistry 13
- Otorhinolaryngology 21
- Critical Care and Intensive Care Medicine 24
Countries citing papers authored by Salma AlBahrani
This map shows the geographic impact of Salma AlBahrani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salma AlBahrani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salma AlBahrani more than expected).
Fields of papers citing papers by Salma AlBahrani
This network shows the impact of papers produced by Salma AlBahrani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salma AlBahrani. The network helps show where Salma AlBahrani may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Salma AlBahrani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 14 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 4 | |
| 10 | 2022 | 5 | |
| 11 | 2022 | 3 | |
| 12 | 2022 | 9 | |
| 13 | 2022 | 5 | |
| 14 | 2022 | 14 | |
| 15 | Clinical Features and Outcome of Low and High Corticosteroids in Admitted COVID-19 Patients | 2021 | 0 |
| 16 | 2021 | 106 | |
| 17 | 2021 | 8 | |
| 18 | 2021 | 6 | |
| 19 | 2018 | 14 | |
| 20 | 2018 | 11 |
About Salma AlBahrani
Salma AlBahrani is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases and Neurology, having authored 28 papers that have together received 265 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (10 papers), Long-Term Effects of COVID-19 (9 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Pneumonia and Respiratory Infections (3 papers), Antibiotic Use and Resistance (3 papers), Antibiotic Resistance in Bacteria (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and COVID-19 and healthcare impacts (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (25 citations), Infectious Diseases (153 citations) and General Dentistry (13 citations). Salma AlBahrani has collaborated with scholars based in Saudi Arabia, United States and Myanmar. Frequent co-authors include Jaffar A. Al‐Tawfiq, Abbas Al Mutair, Saad Alhumaid, Ali A. Rabaan, Raghavendra Tirupathi, Abeer N. Alshukairi, Kuldeep Dhama, Mazin Barry, Mohamad‐Hani Temsah and Manaf AlQahtani. Their work appears in journals such as SHILAP Revista de lepidopterología, International Journal of Environmental Research and Public Health and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.